WallStreetZenWallStreetZen

NASDAQ: NMTC
Neuroone Medical Technologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Neuroone Medical Technologies revenue was $12.10M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $2.7M, up 61.6% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, NMTC annual revenue was $12.1M, with 250.4% growth year-over-year.

NMTC past revenue growth

How has NMTC's revenue growth performed historically?

Company
250.35%
Industry
11.03%
Market
20.97%
NMTC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NMTC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NMTC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NMTC revenue history

Current Revenue
$12.1M
Current Earnings
-$3.6M
Current Profit Margin
-29.8%

Be the first to know when NMTC announces revenue.

NMTC Revenue History By Year

NMTC Yearly RevenueNMTC RevenueNMTC ChangeNMTC Revenue Growth
2025-09-30$12.10M$8.64M+250.35%
2024-09-30$3.45M$45.37k+1.33%
2023-09-30$3.41M$1.29M+60.73%
2022-09-30$2.12M$1.88M+772.60%
2021-09-30$242.96k-$1.68M-87.39%
2020-09-30$1.93MN/AN/A
2019-09-30$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Neuroone Medical Technologies Revenue FAQ

What was NMTC's revenue last quarter?

On Invalid Date, Neuroone Medical Technologies (NASDAQ: NMTC) reported Q3 2025 revenue of $2.74 million up 906.64% year over year. In the same quarter last year, Neuroone Medical Technologies's revenue was $272.28 thousand.

What was Neuroone Medical Technologies's revenue in 2025?

Neuroone Medical Technologies's annual revenue for the twelve months ending Sep 30, 2025 was $12.10 million, a 250.35% increase year over year.

How much does Neuroone Medical Technologies make in a day?

Based on Neuroone Medical Technologies annual revenue for the past five years, NMTC makes an average of $11,682.92 per day.

What was Neuroone Medical Technologies's annual revenue growth in the past year?

As of Q4 2025, Neuroone Medical Technologies's revenue has grown 250.35% year over year. This is 239.33 percentage points higher than the US Medical Devices industry revenue growth rate of 11.03%. Neuroone Medical Technologies's revenue in the past year totaled $12.10 million.

How much does Neuroone Medical Technologies make in a year?

Neuroone Medical Technologies's revenue by year for the past five years is:
  • Neuroone Medical Technologies's revenue for the twelve months ending Sep 30, 2025 was $12.10 million, a 250.35% increase year over year.
  • Neuroone Medical Technologies's annual revenue for Sep 30, 2024 was $3.45 million, a 1.33% increase from 2023.
  • Neuroone Medical Technologies's annual revenue for 2023 was $3.41 million, a 60.73% increase from 2022.
  • Neuroone Medical Technologies's annual revenue for 2022 was $2.12 million, a 772.6% increase from 2021.
  • Neuroone Medical Technologies's annual revenue for 2021 was $242.96 thousand, a 87.39% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.